Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma

31 Jan 2014

Abstract excerpt

PURPOSE: Metastatic urothelial carcinoma of the bladder is associated with multiple somatic copy-number alterations (SCNAs). We evaluated SCNAs to identify predictors of poor survival in patients with metastatic urothelial carcinoma treated with platinum-based chemotherapy. EXPERIMENTAL DESIGN: We obtained overall survival (OS) and array DNA copy-number data from patients with metastatic urothelial carcinoma in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Genomic variations and chromosomal abnormalities
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24486590
DOI: 10.1158/1078-0432.ccr-13-0759

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial CarcinomaPMID 24486590Read ↗

Comparative genomic landscape of primary and metastatic bladder urothelial carcinoma in a large-scale cohort.Semantic proximity Read ↗

Novel tumor subgroups of urothelial carcinoma of the bladder defined by integrated genomic analysis.Semantic proximity Read ↗

Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma.Semantic proximity Read ↗

Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder CancerSemantic proximity Read ↗

<i>CEBPD</i>amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosisSemantic proximity Read ↗

Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial TumorsSemantic proximity Read ↗

The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy.Semantic proximity Read ↗

Combined Analysis of SNP Array Data Identifies Novel CNV Candidates and Pathways in Ependymoma and Mesothelioma.Semantic proximity Read ↗

Mapping of the chromosomal amplification 1p21-22 in bladder cancerSemantic proximity Read ↗

Commentary on "DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma."Semantic proximity Read ↗

Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast CancerSemantic proximity Read ↗

Clinical impact of copy number variation changes in bladder cancer samplesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.